Drug intelligence / Profile preview

6-MOMIPP

Development stage
Preclinical
Lead developer
The University of Toledo
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

6-MOMIPP (3-(6-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one) is a synthetic indole-based chalcone that acts as a potent microtubule-disrupting agent. Developed by researchers at the University of Toledo, it is a structural isomer of 5-MOMIPP. While 5-MOMIPP induces a non-apoptotic cell death called methuosis, 6-MOMIPP causes rapid disruption of microtubules by competing for the colchicine-binding site on tubulin. This leads to mitotic arrest and subsequent caspase-independent cell death. 6-MOMIPP has shown high potency against glioblastoma and melanoma cell lines in vitro and demonstrates the ability to cross the blood-brain barrier in murine models, suggesting potential utility in treating primary and metastatic brain tumors.

Other names
3-(6-methoxy-2-methyl-1H-indol-3-yl)-1-(4-pyridinyl)-2-propene-1-one
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on 6-MOMIPP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-MOMIPP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call